Vipadenant
Vipadenant (CEB-4520, BIIB-014) is a potent and selective adenosine A2a receptor antagonist with a Ki of 1.3 nM, demonstrating 53-fold selectivity over the A1 receptor (Ki=69 nM) . This compound is a valuable research tool for investigating adenosine signaling in neurological disorders, with applications in both in vitro binding assays and in vivo Parkinson's disease models.
Product Specifications
CAS Number
442908-10-3
Product Name Alternative
Inhibit, Inhibitor, CEB 4520, CEB4520, CEB-4520, A1, A3, A2A, Adenosine Receptor, AdenosineReceptor, BIIB 014, BIIB014, BIIB-014, P1 receptor, Vipadenant
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
97.25% (May vary between batches)
Solubility
DMSO:55 mg/mL (171.16 mM)
Smiles
Cc1cc (Cn2nnc3c (nc (N) nc23) -c2ccco2) ccc1N
Molecular Formula
C16H15N7O
Molecular Weight
321.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2114372 Inquire
FITC-Linked Monoclonal Antibody to Alkaline Sphingomyelinase (Alk-Smase)
Sign In for Pricing
View Details